{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:46:00Z","timestamp":1793897160316,"version":"4.8.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001010-00"],"award-info":[{"award-number":["MOH-001010-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001010-00"],"award-info":[{"award-number":["MOH-001010-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Higher resistance rates of\u2009&gt;\u200920% have been noted in <jats:italic>Enterobacteriaceae<\/jats:italic> urinary isolates towards ciprofloxacin and co-trimoxazole\u00a0(C\u00a0+ C) in Singapore, compared with amoxicillin-clavulanate and nitrofurantoin (AC +\u00a0N). This study examined if treatment failure varied between different antibiotics, given different resistant rates, for uncomplicated urinary tract infections (UTIs) managed in primary care. We also aimed to identify gaps for improvement in diagnosis, investigations, and management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study was conducted from 2019 to 2021 on female patients aged 18\u201350 with uncomplicated UTIs at 6 primary care clinics in Singapore. ORENUC classification was used to exclude complicated UTIs. Patients with uncomplicated UTIs empirically treated with amoxicillin-clavulanate, nitrofurantoin, ciprofloxacin or co-trimoxazole were followed-up for 28\u00a0days. Treatment failure was defined as re-attendance for symptoms and antibiotic re-prescription, or hospitalisation for UTI complications. After 2:1 propensity score matching in each group, modified Poisson regression and Cox proportional hazard regression accounting for matched data were used to determine risk and time to treatment failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>3194 of 4253 (75.1%) UTIs seen were uncomplicated, of which only 26% were diagnosed clinically.\u00a0Urine cultures were conducted for 1094 (34.3%) uncomplicated UTIs, of which only 410 (37.5%) had bacterial growth. The most common organism found to cause uncomplicated UTIs was <jats:italic>Escherichia coli<\/jats:italic> (64.6%), with 92.6% and 99.4% of isolates sensitive to amoxicillin-clavulanate and\u00a0nitrofurantoin\u00a0respectively.\u00a0Treatment failure occurred in 146 patients (4.57%). Among 1894 patients treated with AC\u2009+\u2009N matched to 947 patients treated with C\u2009+\u2009C, patients treated with C\u2009+\u2009C were 50% more likely to fail treatment (RR 1.49, 95% CI 1.10\u20132.01), with significantly higher risk of experiencing shorter time to failure (HR 1.61, 95% CI 1.12\u20132.33), compared to patients treated with AC\u2009+\u2009N.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Treatment failure rate was lower for antibiotics with lower reported resistance rates\u00a0(AC\u00a0+\u00a0N). We recommend treating uncomplicated UTIs in Singapore with amoxicillin-clavulanate or nitrofurantoin, based on current local antibiograms.\u00a0Diagnosis, investigations and management of UTIs remained\u00a0sub-optimal.\u00a0Future studies\u00a0should be based on updating antibiograms, highlighting its importance in guideline development.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-023-01282-4","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T16:03:03Z","timestamp":1690905783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Antibiotic treatment failure of uncomplicated urinary tract infections in primary care"],"prefix":"10.1186","volume":"12","author":[{"given":"Sky Wei Chee","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Si Min","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Weng Keong","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Cong","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Hui","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Zhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Chew","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Durai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Anantharajah","family":"Tambyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"issue":"Suppl 1A","key":"1282_CR1","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","volume":"113","author":"B Foxman","year":"2002","unstructured":"Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(Suppl 1A):5S-13S.","journal-title":"Am J Med"},{"issue":"Suppl","key":"1282_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijantimicag.2011.09.009","volume":"38","author":"TEB Johansen","year":"2011","unstructured":"Johansen TEB, Botto H, Cek M, et al. Critical review of current definitions of urinary tract infections and proposal of an EAU\/ESIU classification system. Int J Antimicrob Agents. 2011;38(Suppl):64\u201370.","journal-title":"Int J Antimicrob Agents"},{"key":"1282_CR3","first-page":"399","volume":"40","author":"D Brooks","year":"1990","unstructured":"Brooks D. The management of suspected urinary tract infection in general practice. Br J Gen Pract. 1990;40:399\u2013401.","journal-title":"Br J Gen Pract"},{"key":"1282_CR4","unstructured":"National Institute for Health and Care Excellence (NICE). Urinary tract infections in adults (QS90); NICE, United Kingdom. (2015). https:\/\/www.nice.org.uk\/guidance\/qs90. Accessed 24 Apr 2023."},{"key":"1282_CR5","unstructured":"European Association of Urology. EAU Guidelines on Urological Infections; European Association of Urology. (2022). https:\/\/uroweb.org\/guidelines\/urological-infections. Accessed 24 Apr 2023."},{"issue":"10","key":"1282_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.4065\/73.10.995","volume":"73","author":"RL Thompson","year":"1998","unstructured":"Thompson RL, Wright AJ. General principles of antimicrobial therapy. Mayo Clin Proc. 1998;73(10):995\u20131006.","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"1282_CR7","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1093\/jac\/dkz350","volume":"74","author":"T Ten Doesschate","year":"2019","unstructured":"Ten Doesschate T, Groenwold RHH, Bonten MJM, van Werkhoven CH. Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis. J Antimicrob Chemother. 2019;74(11):3337\u201343.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"1282_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/jac\/48.6.895","volume":"48","author":"RA Lawrenson","year":"2001","unstructured":"Lawrenson RA, Logie JW. Antibiotic failure in the treatment of urinary tract infections in young women. J Antimicrob Chemother. 2001;48(6):895\u2013901.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1282_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1365-2125.2004.02106.x","volume":"58","author":"WG Goettsch","year":"2004","unstructured":"Goettsch WG, Janknegt R, Herings RMC. Increased treatment failure after 3-days\u2019 courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. Br J Clin Pharmacol. 2004;58(2):184\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1282_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/pds.4122","volume":"26","author":"YS Lin","year":"2017","unstructured":"Lin YS, Jan IS, Cheng SH. Comparative analysis of the cost and effectiveness of generic and brand-name antibiotics: the case of uncomplicated urinary tract infection. Pharmacoepidemiol Drug Saf. 2017;26(3):301\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"1282_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/antibiotics11050627","volume":"11","author":"R Neill","year":"2022","unstructured":"Neill R, Gillespie D, Ahmed H. Variation in antibiotic treatment failure outcome definitions in randomised trials and observational studies of antibiotic prescribing strategies: a systematic review and narrative synthesis. Antibiotics. 2022;11(5):627.","journal-title":"Antibiotics"},{"issue":"5","key":"1282_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/00365548809032503","volume":"20","author":"S Ferry","year":"1988","unstructured":"Ferry S, Burman LG, Holm SE. Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand J Infect Dis. 1988;20(5):535\u201344.","journal-title":"Scand J Infect Dis"},{"issue":"451","key":"1282_CR13","first-page":"143","volume":"50","author":"P Davey","year":"2000","unstructured":"Davey P, Steinke D, MacDonald T, Phillips G, Sullivan F. Not so simple cystitis: How should prescribers be supported to make informed decisions about the increasing prevalence of infections caused by drug-resistant bacteria? Br J Gen Pract. 2000;50(451):143\u20136.","journal-title":"Br J Gen Pract"},{"key":"1282_CR14","unstructured":"Ministry of Health Singapore. Principal Causes of Death. Available online: https:\/\/www.moh.gov.sg\/resources-statistics\/singapore-health-facts\/principal-causes-of-death. Accessed 10 Apr 2023."},{"issue":"4","key":"1282_CR15","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/antibiotics12040762","volume":"12","author":"SWC Koh","year":"2023","unstructured":"Koh SWC, Lee VME, Low SH, et al. Prescribing antibiotics in public primary care clinics in singapore: a retrospective cohort study. Antibiotics. 2023;12(4):762.","journal-title":"Antibiotics"},{"issue":"9","key":"1282_CR16","doi-asserted-by":"publisher","first-page":"e00143","DOI":"10.1128\/JCM.00143-19","volume":"57","author":"HJ Ho","year":"2019","unstructured":"Ho HJ, Tan MX, Chen MI, Tan TY, Koo SH, Koong AYL, Ng LP, Hu PL, Tan KT, Moey PKS, Koh EYL, Wong CS, Lye DC, Tan NC. Interaction between antibiotic resistance, resistance genes, and treatment response for urinary tract infections in primary care. J Clin Microbiol. 2019;57(9):e00143-e219.","journal-title":"J Clin Microbiol"},{"key":"1282_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.11622\/smedj.2019088","volume":"60","author":"AQ Chua","year":"2019","unstructured":"Chua AQ, Kwa AL, Tan TY, Legido-Quigley H, Hsu LY. Ten-year narrative review on antimicrobial resistance in Singapore. Singap Med J. 2019;60:387\u201396.","journal-title":"Singap Med J"},{"key":"1282_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12875-016-0547-3","volume":"17","author":"DST Pan","year":"2016","unstructured":"Pan DST, Huang JH, Lee MHM, Yu Y, Chen MI-C, Goh EH, Jiang L, Chong JWC, Leo YS, Lee TH, Wong CS, Loh VWK, Poh AZ, Tham TY, Wong WM, Lim FS. Knowledge, attitudes and practices towards antibiotic use in upper respiratory tract infections among patients seeking primary health care in Singapore. BMC Fam Pract. 2016;17:148.","journal-title":"BMC Fam Pract"},{"key":"1282_CR19","unstructured":"Ministry of Health Singapore. Clinical Practice Guidelines: Use of Antibiotics in Adults. 2006. Available online: https:\/\/www.moh.gov.sg\/docs\/librariesprovider4\/guidelines\/cpg_use-of-antibiotics-in-adults-feb-2006f6e0e4f9dad34a1f8f07666a05ec59a1.pdf?sfvrsn=244726fe_0, Accessed 10 Apr 2023."},{"issue":"656","key":"1282_CR20","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.3399\/bjgp17X688885","volume":"67","author":"T-H Lee","year":"2017","unstructured":"Lee T-H, Wong JG, Lye DC, Chen MI, Loh VW, Leo Y-S, et al. Medical and psychosocial factors associated with antibiotic prescribing in primary care: survey questionnaire and factor analysis. Br J Gen Pract. 2017;67(656):e168\u201377.","journal-title":"Br J Gen Pract"},{"issue":"5","key":"1282_CR21","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the infectious diseases society of america and the european society for microbiology and infectious diseases. Clin Infect Dis. 2011;52(5):e103\u201320.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1282_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.11622\/smedj.2016153","volume":"57","author":"C Wei Tan","year":"2016","unstructured":"Wei Tan C, Chlebicki MP. Urinary tract infections in adults. Singap Med J. 2016;57(9):485\u201390.","journal-title":"Singap Med J"},{"issue":"6","key":"1282_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/fampra\/cmq059","volume":"27","author":"A Kotwani","year":"2010","unstructured":"Kotwani A, Wattal C, Katewa S, Joshi PC, Holloway K. Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract. 2010;27(6):684\u201390.","journal-title":"Fam Pract"},{"issue":"5","key":"1282_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cmi.2019.10.016","volume":"26","author":"N Daneman","year":"2020","unstructured":"Daneman N, Chateau D, Dahl M, et al. Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study. Clin Microbiol Infect. 2020;26(5):613\u20138.","journal-title":"Clin Microbiol Infect"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01282-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-023-01282-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01282-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T16:09:16Z","timestamp":1690906156000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-023-01282-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1282"],"URL":"https:\/\/doi.org\/10.1186\/s13756-023-01282-4","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"assertion":[{"value":"24 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted in accordance with the Declaration of Helsinki national and institutional standards and approved by the NHG Domain-Specific Review Board (DSRB) on 27 January 2022 (2021\/00897).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}